Compare FOR & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FOR | RXRX |
|---|---|---|
| Founded | 2005 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.7B |
| IPO Year | 2007 | 2021 |
| Metric | FOR | RXRX |
|---|---|---|
| Price | $29.07 | $3.36 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $32.67 | $7.50 |
| AVG Volume (30 Days) | 100.4K | ★ 15.3M |
| Earning Date | 04-21-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.79 |
| EPS | ★ 1.63 | N/A |
| Revenue | ★ $1,662,400,000.00 | $74,681,000.00 |
| Revenue This Year | $0.34 | $12.11 |
| Revenue Next Year | $7.73 | $82.52 |
| P/E Ratio | $18.04 | ★ N/A |
| Revenue Growth | 10.14 | ★ 26.92 |
| 52 Week Low | $22.81 | $2.77 |
| 52 Week High | $32.06 | $7.18 |
| Indicator | FOR | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 58.31 |
| Support Level | N/A | $2.87 |
| Resistance Level | N/A | $4.03 |
| Average True Range (ATR) | 0.00 | 0.15 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 0.00 | 92.24 |
Forestar Group Inc is a residential lot development company engaged in land acquisition and development for the sale of finished single-family residential lots to local, regional, and national homebuilders. The company operates through a single real estate segment, which acquires land, installs infrastructure for residential communities, and generates all revenue from lot sales. Its communities mainly support entry-level, first-time move-up, and active-adult homes, with certain communities also marketed to build-to-rent operators. The company generally invests in entitled, short-duration projects that can be developed in phases to align lot production with market demand and support efficient capital deployment.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.